$2.39
-0.07 (-2.85%)
Open$2.45
Previous Close$2.46
Day High$2.47
Day Low$2.38
52W High$4.66
52W Low$2.27
Volume—
Avg Volume129.3K
Market Cap1.28B
P/E Ratio—
EPS$-0.02
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,150.2% upside
Current
$2.39
$2.39
Target
$29.88
$29.88
$20.40
$29.88 avg
$34.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 198.52M | 169.90M | 608.59M |
| Net Income | -12,774,022 | -9,839,626 | 77.66M |
| Profit Margin | -6.4% | -6.1% | 12.8% |
| EBITDA | -35,102,597 | -28,541,139 | 120.12M |
| Free Cash Flow | — | — | 67.66M |
| Rev Growth | +16.8% | +16.8% | +15.9% |
| Debt/Equity | — | — | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |